WAVE LIFE SCIENCES LTD. Prepaid Expense and Other Assets, Current
WAVE LIFE SCIENCES LTD. (WVE) had Prepaid Expense and Other Assets, Current of $21.25 million as of 2019-09-30, per its 10-Q filed 2019-11-05.
Discontinued › Notes › and Other Assets
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2019-11-05
- 2019-09-30: Prepaid Expense and Other Assets, Current $21.25M.
- 2019-06-30: Prepaid Expense and Other Assets, Current $16.68M.
- 2019-03-31: Prepaid Expense and Other Assets, Current $17.46M.
- 2018-12-31: Prepaid Expense and Other Assets, Current $17.45M.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2019-09-30 | $21.25M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $16.68M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $17.46M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $17.45M 10-Q · filed 2019-11-05 | |
| 2018-09-30 | $12.67M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $11.24M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $7.47M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $6.99M 10-K · filed 2019-03-01 | $7.99M 10-K · filed 2018-03-12 |
| 2017-09-30 | $5.37M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $3.83M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $3.30M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $1.48M 10-K · filed 2018-03-12 | |
| 2016-09-30 | $625.00K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $2.18M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $580.00K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $146.00K 10-K · filed 2017-03-16 | |
| 2015-09-30 | $147.00K 10-Q · filed 2015-12-17 | |
| 2014-12-31 | $103.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |